Home
>
National Drug Code (NDC)
>
Metoprolol Succinate
Metoprolol Succinate - 51079-171-03 - (metoprolol succinate)
Drug Information of Metoprolol Succinate
| Product NDC: | 51079-171 |
| Proprietary Name: | Metoprolol Succinate |
| Non Proprietary Name: | metoprolol succinate |
| Active Ingredient(s): | 100 mg/1 & nbsp; metoprolol succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Metoprolol Succinate
| Product NDC: | 51079-171 |
| Labeler Name: | Mylan Institutional Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202033 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120905 |
Package Information of Metoprolol Succinate
| Package NDC: | 51079-171-03 |
| Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-171-03) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-171-01) |
NDC Information of Metoprolol Succinate
| NDC Code | 51079-171-03 |
| Proprietary Name | Metoprolol Succinate |
| Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-171-03) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (51079-171-01) |
| Product NDC | 51079-171 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | metoprolol succinate |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20120905 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Institutional Inc. |
| Substance Name | METOPROLOL SUCCINATE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
